Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting

• Phill-Seung Jung,

  Affiliation Division of Gynecolgic Oncology, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea

  ⨯
• Dae-Yeon Kim,

  Affiliation Division of Gynecolgic Oncology, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea

  ⨯
• Shin-Wha Lee,

  Affiliation Division of Gynecolgic Oncology, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea

  ⨯
• Jeong-Yeol Park,

  Affiliation Division of Gynecolgic Oncology, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea

  ⨯
• Dae-Shik Suh,

  Affiliation Division of Gynecolgic Oncology, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea

  ⨯
• Jong-Hyeok Kim,

  Affiliation Division of Gynecolgic Oncology, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea

  ⨯
• Yong-Man Kim,

  Affiliation Division of Gynecolgic Oncology, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea

  ⨯
• Young-Tak Kim,

  Affiliation Division of Gynecolgic Oncology, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea

  ⨯
• Joo-Hyun Nam

  * E-mail: jhnam@amc.seoul.kr

  Affiliation Division of Gynecolgic Oncology, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea

  ⨯